Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships

Ottawa Hospital Research Institute

$105,000.00

A role for integrin-linked kinase in oligodendrocyte mediated myelination of the central nervous system.

EF 2010-11

Résumé
Our project specific aim is to better understand the role of a small protein, integrin-linked kinase (ILK), in helping the cells of your brain produce the fatty insulating substance myelin. Previous work in the field has shown a role for ILK in myelin production when cells are grown in a dish. We have, therefore, generated genetically modified mice lacking the ILK protein specifically in myelin producing cells of the central nervous system. During early development, these mice display defects in their ability to engulf nerves with myelin. Interestingly, as the mice age, a compensatory mechanism is activated,allowing nerves to be properly surrounded by a thick layer of myelin. Future work is aimed at better understanding the biological components involved in the compensatory mechanism; whether by another molecule with similar functions to ILK, or complete replacement of the ILK deficient cells by other normal fully functional myelin producing cells. Elucidating the mechanisms by which myelin is produced is fundamental to our understanding of Multiple Sclerosis, a debilatating disease affecting an estimated 75,000 Canadians. Our work will allow us to discern important molecular mechanisms involved in communication between the myelin producing cells and their cellular environment. Through our understanding of the mechanisms governing myelin production we can develop new therapies to aid those suffering from Multiple Sclerosis.
Programme
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Emplacement
Ontario, Canada
Type de bénéficiaire
Other
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
229600
Name
Michalski John-Paul
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
A role for integrin-linked kinase in oligodendrocyte mediated myelination of the central nervous system.
Programtype2
Studentship Programs
Orgnameinp2
Ottawa Hospital Research Institute
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Cytoskeleton; Focal Adhesion Complexes; Imaging; Multiple Sclerosis; Myelin; Oligodendrocyte; Organotypic Slice Culture; Remyelination; Transgenic Mice
Abstract
Our project specific aim is to better understand the role of a small protein, integrin-linked kinase (ILK), in helping the cells of your brain produce the fatty insulating substance myelin. Previous work in the field has shown a role for ILK in myelin production when cells are grown in a dish. We have, therefore, generated genetically modified mice lacking the ILK protein specifically in myelin producing cells of the central nervous system. During early development, these mice display defects in their ability to engulf nerves with myelin. Interestingly, as the mice age, a compensatory mechanism is activated,allowing nerves to be properly surrounded by a thick layer of myelin. Future work is aimed at better understanding the biological components involved in the compensatory mechanism; whether by another molecule with similar functions to ILK, or complete replacement of the ILK deficient cells by other normal fully functional myelin producing cells. Elucidating the mechanisms by which myelin is produced is fundamental to our understanding of Multiple Sclerosis, a debilatating disease affecting an estimated 75,000 Canadians. Our work will allow us to discern important molecular mechanisms involved in communication between the myelin producing cells and their cellular environment. Through our understanding of the mechanisms governing myelin production we can develop new therapies to aid those suffering from Multiple Sclerosis.
Competitiondate
201010
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Michalski, John-Paul
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~